angiotensin ii has been researched along with hydroxyurea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, DM; Almeida, CB; Brugnerotto, AF; Conran, N; Costa, FF; dos Santos, AF; Franco-Penteado, CF; Lanaro, C; Leonardo, FC; Pallis, FR; Roversi, FM | 1 |
| Antunes, E; Baldanzi, G; Billis, A; Brito, PL; Chweih, H; Conran, N; Costa, FF; de Oliveira, MG; Dos Santos, AF; Favero, ME; Ferreira, WA; Franco-Penteado, CF; Gotardo, EMF; Leonardo, FC; Mashima, DA; Saad, STO; Silva, JAF; Zaidan, BC | 1 |
2 other study(ies) available for angiotensin ii and hydroxyurea
| Article | Year |
|---|---|
Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease.
Topics: Anemia, Sickle Cell; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hydroxyurea; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptidyl-Dipeptidase A; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2014 |
Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diastole; Disease Models, Animal; Female; Humans; Hydroxyurea; Male; Mice; Mice, Inbred C57BL; Middle Aged; Peptidyl-Dipeptidase A; Real-Time Polymerase Chain Reaction; Renin; Renin-Angiotensin System; Systole; Young Adult | 2022 |